Probiotic dietary supplement and stool evaluation to improve ileal pouch health

Phase 1

• Conditions: Pouchitis; Ulcerative colitis; Oral and Gastrointestinal - Inflammatory bowel disease

• Registration Number: ACTRN12613000544774
• Lead Sponsor: niversity of Otago

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-05-15
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

Functioning ileal J pouch for ulcerative colitis

Exclusion Criteria

unable to provide informed consent

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Clinical measure of pouch function using clinical portion of the Pouchitis Disease Activity Index.[after 8 weeks of probiotic]

Secondary Outcome Measures

Name	Time	Method
Quality of life using Short Form 12.[After 8 weeks of probiotic.];Presence of probiotic in stool[weeks 0, 1, 2, 4, 8, and 3 weeks post treatment];DNA profile of selected bacteria[weeks 0, 1, 2, 4, 8, and 3 weeks post treatment];Faecal calprotectin[weeks 0, 1, 2, 4, 8, and 3 weeks post treatment]